Drug Price Trends for NDC 52536-0882

Average Pharmacy Cost for 52536-0882

Drug Name	NDC	Price/Unit ($)	Unit	Date
VERAPAMIL SR 180 MG CAPSULE	52536-0882-01	1.01051	EACH	2025-04-23
VERAPAMIL SR 180 MG CAPSULE	52536-0882-01	1.04293	EACH	2025-03-19
VERAPAMIL SR 180 MG CAPSULE	52536-0882-01	0.97639	EACH	2025-02-19
VERAPAMIL SR 180 MG CAPSULE	52536-0882-01	1.02113	EACH	2025-02-05

Best Wholesale Price for NDC 52536-0882

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for Drug NDC: 52536-0882

The pharmaceutical industry is constantly evolving, with drug prices and market dynamics playing a crucial role in shaping its future. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug with National Drug Code (NDC) 52536-0882, examining various factors that influence its position in the pharmaceutical landscape.

Understanding the National Drug Code (NDC)

Before we dive into the specifics of NDC 52536-0882, it's essential to understand the significance of the National Drug Code system. The NDC is a unique, three-segment number assigned by the U.S. Food and Drug Administration (FDA) to human drugs in the United States[5]. This universal product identifier plays a crucial role in drug listing, reimbursement, and supply chain management.

The Structure of NDC

The NDC consists of three segments:

1. Labeler Code: Assigned by the FDA to the drug manufacturer, repacker, or distributor.
2. Product Code: Identifies the specific strength, dosage form, and formulation.
3. Package Code: Indicates the package size and type.

Currently, the NDC is limited to 10 digits, with various configurations such as 4-4-2, 5-3-2, or 5-4-1[5].

The Impending NDC Format Change

The pharmaceutical industry is on the brink of a significant change in the NDC format. The FDA is running out of available NDC numbers, necessitating a restructuring of the system[9]. This change will have far-reaching implications for the entire pharmaceutical supply chain, affecting everything from manufacturing to pharmacy operations.

Nearly every step in pharmaceutical product manufacturing, distribution, and pharmacy operation uses the NDC code. But now, the Food and Drug Administration (FDA) is running out of NDC numbers, requiring a new look at how it is structured.[9]

Market Analysis for NDC 52536-0882

While specific information about NDC 52536-0882 is not provided in the search results, we can analyze broader market trends that are likely to impact this drug along with others in the pharmaceutical industry.

Drug Price Inflation Projections

According to Vizient's latest Pharmacy Market Outlook, drug price inflation is projected to grow at 3.8% in the near future. This increase, the highest since July 2019, is primarily driven by specialty pharmaceuticals, including the rising utilization of weight loss drugs[2].

Impact of Specialty Pharmaceuticals

Specialty pharmaceuticals, particularly in areas like weight loss and gene therapies, are expected to significantly influence drug pricing and market dynamics. The anticipated expansion of gene therapies is likely to further increase provider spending[2].

Generic Drug Competition and Pricing

For generic drugs, market competition plays a crucial role in determining prices. A study on Medicare Part D demonstrated that markets with about 3 competitors saw a 20% decline in prices compared to pre-generic entry prices. In markets with 10 or more competitors, prices declined by approximately 70%[4].

Key Trends Shaping the Pharmaceutical Industry in 2025

As we look towards 2025, several trends are expected to shape the pharmaceutical industry, which will likely impact NDC 52536-0882 and other drugs:

1. Increased focus on prevention and personalized medicine
2. Data-driven, customized treatments based on genetics and behavior
3. Emphasis on prediction and early intervention
4. Shift towards more accessible and convenient care delivery settings[7]

Policy and Regulatory Changes

The changing policy landscape, particularly in the United States, is expected to play a significant role in shaping the pharmaceutical market. The incoming administration's policies on healthcare, tariffs, taxes, and M&A oversight could accelerate changes in the industry[7].

Price Projections for NDC 52536-0882

While specific price projections for NDC 52536-0882 are not available in the provided search results, we can infer potential trends based on industry-wide projections and market dynamics.

Factors Influencing Price

Several factors are likely to influence the price of NDC 52536-0882:

1. Overall drug price inflation (projected at 3.8%)
2. Competition in its specific drug category
3. Whether it's a brand-name or generic drug
4. Potential inclusion in specialty pharmaceutical categories
5. Policy and regulatory changes

Generic vs. Brand-Name Considerations

If NDC 52536-0882 is a generic drug, its price is likely to be influenced by the number of competitors in the market. As we've seen from the Medicare Part D study, increased competition generally leads to lower prices[4].

On the other hand, if it's a brand-name drug, especially in a specialty category, it may contribute to the projected price inflation and could see more significant price increases.

Market Dynamics and Future Outlook

The pharmaceutical market is expected to undergo fundamental changes in the coming years. These changes will likely affect NDC 52536-0882 along with other drugs in the market.

Shift in Value Creation

The health ecosystem is moving towards a focus on prevention, personalization, prediction, and point of care. This shift could impact the demand and pricing for various drugs, including NDC 52536-0882, depending on its therapeutic category and alignment with these trends[7].

Capital Market Perceptions

Investors seem to be recognizing that many pharmaceutical business models are becoming less sustainable. This is reflected in the decline of the median enterprise-value-to-EBITDA multiple for pharmaceutical companies from 13.6X in 2018 to 11.5X in recent times[7].

Implications for Stakeholders

The evolving market dynamics and potential price changes for NDC 52536-0882 and other drugs have significant implications for various stakeholders in the pharmaceutical industry.

For Manufacturers

Drug manufacturers need to adapt to the changing landscape by:

• Focusing on innovation in areas aligned with the shift towards prevention and personalized medicine
• Preparing for increased competition, especially in the generic drug market
• Adapting to potential regulatory changes, including the upcoming NDC format change

For Healthcare Providers

Healthcare providers should:

• Anticipate potential increases in drug spending, particularly for specialty pharmaceuticals
• Consider the impact of drug prices on treatment decisions and patient care
• Prepare for the systemic changes that will come with the NDC format update

For Payers

Insurance companies and other payers need to:

• Factor in projected drug price increases in their planning and pricing strategies
• Consider the potential impact of increased utilization of specialty drugs, including weight loss medications
• Prepare for potential changes in reimbursement systems due to the NDC format update

Preparing for the NDC Format Change

The impending change in the NDC format will have far-reaching implications for the entire pharmaceutical industry, including how NDC 52536-0882 is identified and processed.

Scope of the Change

The NDC format change is expected to impact nearly every system that touches healthcare where medication use happens. This includes systems involved in manufacturing, distribution, pharmacy operations, and healthcare delivery[9].

Timeline and Preparation

While the exact timeline for the NDC format change is not specified in the search results, industry experts suggest that preparation for this change could take a decade or longer. Organizations across the pharmaceutical supply chain need to start planning for this change, which has been likened to the Y2K preparations in terms of its scope and impact[9].

Key Takeaways

1. Drug price inflation is projected to grow at 3.8%, driven largely by specialty pharmaceuticals.
2. The pharmaceutical industry is preparing for a significant change in the NDC format, which will impact all aspects of drug manufacturing, distribution, and use.
3. Market dynamics are shifting towards prevention, personalization, prediction, and point of care.
4. Generic drug prices are heavily influenced by market competition, with more competitors generally leading to lower prices.
5. The changing policy landscape, particularly in the U.S., is expected to play a significant role in shaping the pharmaceutical market.
6. Stakeholders across the pharmaceutical industry need to prepare for these changes, including potential price fluctuations and the upcoming NDC format change.

FAQs

1. Q: What is the National Drug Code (NDC)? A: The National Drug Code is a unique, three-segment number assigned by the FDA to human drugs in the United States. It serves as a universal product identifier for drugs.

2. Q: Why is the NDC format changing? A: The FDA is running out of available NDC numbers, necessitating a restructuring of the system to accommodate more drugs.

3. Q: How might the NDC format change impact drug prices? A: While the format change itself doesn't directly impact prices, the associated system updates and potential changes in drug identification and reimbursement processes could indirectly influence pricing.

4. Q: What factors are driving the projected 3.8% increase in drug prices? A: The increase is primarily driven by specialty pharmaceuticals, including the rising utilization of weight loss drugs and the anticipated expansion of gene therapies.

5. Q: How can healthcare providers prepare for potential drug price increases? A: Healthcare providers should anticipate potential increases in drug spending, consider the impact on treatment decisions, and prepare for systemic changes associated with the NDC format update.

Sources cited: [2] https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-3-8-drug-price-increase-driven-by-specialty-pharmaceuticals [4] https://aspe.hhs.gov/sites/default/files/migrated_legacy_files/198346/medicare-part-d-generic-comp.pdf [5] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [7] https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html [9] https://www.wolterskluwer.com/en/expert-insights/are-you-prepared-for-a-major-industry-change-to-the-national-drug-code-ndc-number